WASHINGTON, April 26 (Reuters) - U.S. Supreme Court justices
on Wednesday struggled over whether to speed up the time it
takes to bring to the market copycat versions of biologic drugs,
expensive medicines that can generate billions of dollars in
sales for drug makers.
Read more
No comments:
Post a Comment